Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Trader’s Buzz: Alexion Pharmaceuticals (ALXN), Moneygram (MGI), Fate Therapeutics (FATE), PlasmaTech (PTBI)

Shares of Synageva BioPharma Corp. (GEVA) are surging $119, or 125%, to $215.16 in early trading on Wednesday after the company announced its $8.4-billion acquisition by Alexion Pharmaceuticals (ALXN). Alexion said it will pay $115 in cash and a portion of its stock for each Synageva share. That puts the total per-share price at $230 […] View the full post at: Trader’s Buzz: Alexion Pharmaceuticals (ALXN), Moneygram (MGI), Fate Therapeutics (FATE), PlasmaTech (PTBI) Related posts: Cramer: Medicis Pharmaceuticals Looks Attractive Walt Disney to Acquire Marvel Entertainment for $4B Russian Tech Group Offers to Invest $200 mln in Facebook
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.